In 2023, private non-profit expenditure on R&D in medical and health sciences in Japan stood at a notable benchmark before embarking on a gradual upward trajectory. Forecasted data indicates a year-over-year increase of approximately 1.83% annually up to 2028. By 2028, the expenditure is expected to reach 73.59 billion Japanese Yens, with a compound annual growth rate (CAGR) of about 1.75% over this five-year period. These figures suggest a consistent but modest investment growth pattern.
Future trends to watch for include:
- Potential shifts in government policy affecting non-profit funding.
- Advancements in technology which may impact R&D efficiency and costs.
- Global economic influences that could alter funding availability.
